Serum BDNF Role as a Biomarker for Stroke Rehabilitation "BDNF"


Phase N/A Results N/A

Summary of Purpose

This study aims to develop the quantitative biomarker to establish the individualized strategy in stroke rehabilitation. Brain-derived neurotrophic factor (BDNF) acts on certain neurons of the central nervous system (CNS) helping to support the survival of existing neurons, and encourage the growth and differentiation of new neurons and synapses. BDNF in CNS can be assessed by analysing serum BDNF. The final...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 May 2017.

1 Feb 2017 21 May 2017 31 Dec 2018 31 May 2019 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available


  • Won Hyuk Chang, MD, PhD